To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.
The bill’s titles are written by its sponsor.
Sponsor and status
- Introduced:
Feb 28, 2017
- Status:
-
Introduced on Feb 28, 2017
This bill is in the first stage of the legislative process. It was introduced into Congress on February 28, 2017. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.
- Prognosis:
-
3% chance of being enacted according to Skopos Labs (details)
History
|
Feb 28, 2017
|
|
Introduced
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber. |
|
|
If this bill has further action, the following steps may occur next: | |
|
—
|
|
Passed Committee
|
|
—
|
|
Passed House
|
|
—
|
|
Passed Senate
|
|
—
|
|
Signed by the President
|
H.R. 1245 is a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
“H.R. 1245 — 115th Congress: Affordable and Safe Prescription Drug Importation Act.” www.GovTrack.us. 2017. October 19, 2018 <https://www.govtrack.us/congress/bills/115/hr1245>
- show another citation format:
- APA
- Blue Book
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.
